Drug Discovery World

JULY 1, 2024

Following a trip to Copenhagen, Denmark, DDW’s Megan Thomas reflects on the Novo Nordisk Foundation’s efforts to tackle cardiometabolic diseases. The World Health Organization (WHO) reports that cardiovascular diseases (CVDs) are the leading cause of death globally, stating that an estimated 17.9 billion DKK ($11.97

Disease 162

Disease International Research Science 162

Drug Discovery World

FEBRUARY 26, 2024

Reece Armstrong speaks to Kathryn Golden , SVP Technical Operations and Manufacturing, bit.bio, about novel technologies, and methods to manufacture human cells for therapies so more patients can access these treatments. Cell therapies have emerged as transformative and potentially curative treatments across a range of disease areas.

Therapies 130

Therapies Treatment Engineering Disease 130

The Pharma Data

NOVEMBER 11, 2020

About Sequana Medical Sequana Medical is a commercial stage medical device company developing the alfa pump platform for the management of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. and EU5 by 2026. GHENT, Belgium, Nov.

Therapies 40

Therapies Marketing Disease Clinical Research 40

The Pharma Data

DECEMBER 16, 2020

About Sequana Medical Sequana Medical is a commercial stage medical device company developing the alfa pump platform for the management of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. and EU5 by 2026. GHENT, Belgium, Dec.

Therapies 40

Therapies Marketing Disease Clinical Research 40

The Pharma Data

OCTOBER 14, 2020

15, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV ( Euronext Brussels: SEQUA ) , an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces the appointments of Dr. Michael Felker and Dr. James Udelson as new Heart Failure Scientific Advisors. GHENT, Belgium, Oct.

Clinical Trials 40

Clinical Trials Clinical Research Therapies Marketing 40

Drug Discovery World

FEBRUARY 22, 2024

Dementia is the only major cause of death without a treatment to prevent, slow or stop disease progression. “In With the breadth and range of central nervous system disorders – for example Parkinson’s disease and multiple sclerosis – facing the global population there is an unmet need within this area of drug discovery.

Drugs 147

Drugs Clinical Trials Disease Therapies 147